Seoul Bio Forum

The Event Overview

The Korea-US Biotech Startup Investment Forum is a prestigious collaborative event hosted by Invest Seoul and Seoul Bio Hub, showcasing innovative Korean biotech startups. This exclusive gathering brings together global investors and industry experts for an engaging pitching session featuring cutting-edge Korean biotech companies specializing in various healthcare technologies, from AI-driven diagnostics to novel therapeutics.

​The forum will feature a high-level panel discussion with participants from Pfizer, successful Korean/US venture-backed biotech entrepreneurs, and prominent US investors, including Korean-American investment professionals.

​Panel Discussion

​​The forum will feature an insightful panel discussion with distinguished experts, including:

• ​​Shaan Gandhi (VP) from Pfizer

• ​​Laura Bae from Silver Spur Therapeutics: Korean American entrepreneur with US VC funding experience

• ​​An Investor from SV Investment (Boston): US/KOR investor with expertise in cross-border biotech investments

• ​​American investment professional focused on healthcare opportunities.

​This unique networking opportunity aims to foster international collaboration between Korean biotech innovators and the global investment community, opening doors for strategic partnerships and investment opportunities in both Korean and American markets.

​Featured Startups

1. ​AIVIS - AI-powered digital pathology solutions enabling fast and accurate cancer diagnostics through innovative quantification technology, improving patient outcomes worldwide.

2. ​Astrogen - Developing innovative therapeutics for rare neurological disorders through clinician-led development and rapid commercialization pathways to address urgent patient needs.

3. ​Cureverse - A pioneering biopharmaceutical company developing novel therapies for brain diseases and multiple sclerosis with revolutionary small-molecule drug discovery technologies.

4. ​Galux - Revolutionizing drug discovery with an integrated in silico platform combining physics, chemistry, and artificial intelligence to accelerate therapeutic development.

5. ​VSPharmTech - Developing innovative radiosensitizers to enhance cancer treatment efficacy and novel compounds to inhibit cancer cell migration and metastasis.

6. ​MediMabBio - Creating precision immunotherapeutics through rational protein design to address serious cancer and autoimmune diseases with novel mechanisms of action.

7. ​CellabMed - Pioneering CAR-T cell therapies and therapeutic antibodies for rare and intractable cancers with a fully integrated R&D system from basic research to clinical development.

8. ​CellKey - Providing AI-powered cloud solutions for complex multi-omics data analysis to accelerate biomarker discovery and drug development with unprecedented efficiency.

9. ​Exollence - Developing next-generation exosome-based drug delivery platforms (SWEET™) for targeted therapeutic delivery across various disease applications.

10. ​Proteina - Creating an innovative platform for protein-protein interaction analysis using single-molecule co-immunoprecipitation technology to accelerate biomarker and therapeutic development.

​Join us for this exclusive opportunity to witness the future of Korean biotech innovation and explore potential investment and partnership opportunities in this rapidly evolving sector.